Based on our Physician & Payer Forum report entitled Biologics and Formulations for Inflammatory and Nociceptive Pain: Will These Agents Gain Widespread Physician and Payer Acceptance Despite a Crowded Market?, Decision Resources is offering an exclusive webinar entitled Inflammatory and Nociceptive Pain: Physician and Payer Insights Regarding the First-in-Class Biologic Analgesic, Tanezumab. Because this webinar features major report findings, it is ONLY available to purchasers of this report. This webinar was held on June 16, 2010. Contact us to learn how can purchase this Physician & Payer Forum report and access a recorded playback of this event. Click here to view the invite.
Send to a Friend